You are using an older browser version. Please use a supported version for the best MSN experience.

Watch CNBC's interview with Eli Lilly's chief scientific officer on the new Covid antibody drug

A study found that Eli Lilly's antibody drug showed recipients had an 80 percent lower risk of symptomatic Covid-19 vs. residents in the same nursing home facility. Dr. Dan Skovronsky, Lilly Chief Scientific Officer, joins CNBC's Meg Tirrell on 'The Exchange' to discuss the trial and findings.
image beaconimage beaconimage beacon